Of course IGF 1 returns to normal after cessation of Tamoxifen however decreasing IGF 1 significantly during a PCT is not beneficial. I shouldn't say that Nolvadex is garbage because it's honestly the first thing I would take when preventing gyno and hands down the most effective in that aspect however I feel like it lowers IGF 1 too much during a PCT.More on a opinion/non scientific side of things:
Why do you consider Nolva as a garbage SERM for recovering HPTA? I'ts pretty widely used for PCT and seems to be effective. Is it only the lowering of IGF-1? It's only temporary. And the gyno protection it also provides is a nice addition. Torem should be even better though, like you said.
You keep saying how Clomid is superior to Enclo, but haven't provided anything to base that off on. Again, I don't know all the effects, that the Zuclo isomer has/may have, so I'm not saying, that I know the Enclo to be better. But all the bit of info I've read about it has been negative, pretty much (for what we use SERM's for). I guess I need to try and do more research on it.
I don't think the half life is very meaningful for PCT purposes. If you want to have Enclo in your system for 8 weeks for example, then you take it for 7 weeks. If you want to have a SERM with longer half life in your system for 8 weeks, then you take it for less time.
As for the zuclo being "negative" there is not any literature that I'm aware of that has isolated the zuclo isomer or performed any significant clinical trials in humans. My personal opinion is that the zuclo isomer is beneficial as we have both androgen and estrogen receptors at the HPTA . During a PCT phase it would be beneficial for both AR and ER to be occupied at the same time in the brain opposed to just activating AR you would be missing out big time on IGF 1 signaling
Last edited: